Capital Analysts LLC’s Aurora Cannabis ACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-5
Closed 1361
2024
Q4
$0 Buy
+5
New +$25 ﹤0.01% 1290
2021
Q4
Sell
-83
Closed -$6K 999
2021
Q3
$6K Hold
83
﹤0.01% 833
2021
Q2
$8K Sell
83
-9
-10% -$780 ﹤0.01% 770
2021
Q1
$9K Buy
92
+9
+11% +$1.01K ﹤0.01% 797
2020
Q4
$7K Sell
83
-2
-2% -$146 ﹤0.01% 597
2020
Q3
$4K Hold
85
﹤0.01% 659
2020
Q2
$11K Sell
85
-9
-10% -$1.02K ﹤0.01% 533
2020
Q1
$10K Hold
94
﹤0.01% 511
2019
Q4
$24K Hold
94
﹤0.01% 475
2019
Q3
$49K Buy
94
+6
+7% +$4.45K 0.01% 385
2019
Q2
$82K Buy
88
+3
+4% +$3.01K 0.01% 298
2019
Q1
$92K Hold
85
0.01% 272
2018
Q4
$51K Buy
+85
New +$62.7K 0.01% 313

Other funds holding ACB

Capital Analysts LLC's ACB Position: Q1 2025 in Review

Capital Analysts LLC sold out of Aurora Cannabis (ACB) in Q1 2025, closing a stake of 5 shares.

Capital Analysts LLC first reported a position in ACB in Q4 2018 and held it in 13 quarters. The position peaked at $92K in Q1 2019. 156 funds tracked by Wall St. Rank hold ACB as of Q1 2025.

  • Capital Analysts LLC reported no remaining Aurora Cannabis position as of Q1 2025 after selling out during the quarter.
  • Capital Analysts LLC sold 5 Aurora Cannabis shares in Q1 2025.
  • Capital Analysts LLC first reported a position in Aurora Cannabis in Q4 2018 and held it in 13 quarters.
  • Capital Analysts LLC's Aurora Cannabis position peaked at $92K in Q1 2019.
  • 156 funds tracked by Wall St. Rank held Aurora Cannabis as of Q1 2025.

Based on Capital Analysts LLC's 13F filing for Q1 2025, filed 14 May 2025.